Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Digas Ngolo Tete"'
Autor:
Andrea Kuemmerle, Caecilia Schmid, Sonja Bernhard, Victor Kande, Wilfried Mutombo, Medard Ilunga, Ismael Lumpungu, Sylvain Mutanda, Pathou Nganzobo, Digas Ngolo Tete, Mays Kisala, Christian Burri, Severine Blesson, Olaf Valverde Mordt
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 15, Iss 11 (2021)
Background Nifurtimox-eflornithine combination therapy (NECT) for the treatment of second stage gambiense human African trypanosomiasis (HAT) was added to the World Health Organization’s Essential Medicines List in 2009 after demonstration of its n
Externí odkaz:
https://doaj.org/article/97cd5f838f9b406bbc6d7a30a0545e1c
Autor:
Victor Kande Betu Ku Mesu, DPH, Wilfried Mutombo Kalonji, MD, Clélia Bardonneau, MSc, Olaf Valverde Mordt, MSc, Digas Ngolo Tete, MPH, Séverine Blesson, MSc, François Simon, MSc, Sophie Delhomme, MSc, Sonja Bernhard, PhD, Hélène Mahenzi Mbembo, MD, Christian Mpia Moke, MD, Steven Lumeya Vuvu, MMed, Junior Mudji E'kitiak, MD, Felix Akwaso Masa, MD, Melchias Mukendi Ilunga, MD, Dieudonné Mpoyi Muamba Nzambi, MD, Tim Mayala Malu, MD, Serge Kapongo Tshilumbwa, MD, Franck Botalema Bolengi, MD, Mathieu Nkieri Matsho, MD, Crispin Lumbala, MPH, Bruno Scherrer, PhD, Nathalie Strub-Wourgaft, MD, Antoine Tarral, MD
Publikováno v:
The Lancet Global Health, Vol 9, Iss 7, Pp e999-e1008 (2021)
Summary: Background: Staging and treatment of human African trypanosomiasis caused by Trypanosoma brucei gambiense (g-HAT) required lumbar puncture to assess cerebrospinal fluid (CSF) and intravenous drugs that cross the blood–brain barrier for lat
Externí odkaz:
https://doaj.org/article/fc53e144d24e4957ad24602246c04574
Autor:
Hélène Mahenzi Mbembo, Mathieu Nkieri Matsho, Bruno Scherrer, Steven Lumeya Vuvu, Wilfried Mutombo Kalonji, Franck Botalema Bolengi, Olaf Valverde Mordt, Sonja Bernhard, Sophie Delhomme, Séverine Blesson, Antoine Tarral, Tim Mayala Malu, Clélia Bardonneau, Serge Kapongo Tshilumbwa, Dieudonné Mpoyi Muamba Nzambi, Felix Akwaso Masa, François Simon, Melchias Mukendi Ilunga, Crispin Lumbala, Digas Ngolo Tete, Nathalie Strub-Wourgaft, Victor Kande Betu Ku Mesu, Christian Mpia Moke, Junior Mudji E'kitiak
Publikováno v:
The Lancet. Global Health
The Lancet Global Health, Vol 9, Iss 7, Pp e999-e1008 (2021)
The Lancet Global Health, Vol 9, Iss 7, Pp e999-e1008 (2021)
Summary Background Staging and treatment of human African trypanosomiasis caused by Trypanosoma brucei gambiense (g-HAT) required lumbar puncture to assess cerebrospinal fluid (CSF) and intravenous drugs that cross the blood–brain barrier for late-
Autor:
Sylvain Mutanda, Medard Ilunga, Olaf Valverde Mordt, Digas Ngolo Tete, Wilfried Mutombo, Caecilia Schmid, Victor Kande, Séverine Blesson, Andrea Kuemmerle, Ismael Lumpungu, Christian Burri, Mays Kisala, Sonja Bernhard, Pathou Nganzobo
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 15, Iss 11, p e0009903 (2021)
PLoS Neglected Tropical Diseases, Vol 15, Iss 11 (2021)
PLoS Neglected Tropical Diseases
PLoS Neglected Tropical Diseases, Vol 15, Iss 11 (2021)
PLoS Neglected Tropical Diseases
Background Nifurtimox-eflornithine combination therapy (NECT) for the treatment of second stage gambiense human African trypanosomiasis (HAT) was added to the World Health Organization’s Essential Medicines List in 2009 after demonstration of its n
Autor:
Victor Kande Betu Kumesu, Wilfried Mutombo Kalonji, Clélia Bardonneau, Olaf Valverde Mordt, Digas Ngolo Tete, Séverine Blesson, François Simon, Sophie Delhomme, Sonja Bernhard, Pathou Nganzobo Ngima, Hélène Mahenzi Mbembo, Jean-Pierre Fina Lubaki, Steven Lumeya Vuvu, Willy Kuziena Mindele, Médard Ilunga Wa Kyhi, Guylain Mandula Mokenge, Lewis Kaninda Badibabi, Augustin Kasongo Bonama, Papy Kavunga Lukula, Crispin Lumbala, Bruno Scherrer, Nathalie Strub-Wourgaft, Antoine Tarral
Publikováno v:
The Lancet. Global health. 10(11)
BACKGROUND: Fexinidazole has been reported as an effective oral monotherapy against non-severe gambiense human African trypanosomiasis in a recent trial in adults. We aimed to assess the safety and efficacy of fexinidazole in children across all dise
Autor:
Bruno Scherrer, Victor Kande Betu Ku Mesu, Crispin Lumbala, Olaf Valverde Mordt, Nathalie Strub-Wourgaft, Wilfried Mutombo Kalonji, Séverine Blesson, Willy Kuziena, Jean Pierre Fina Lubaki, Steven Lumeya Vuvu, Pathou Nganzobo Ngima, Augustin Kasongo Bonama, François Simon, Lewis Kaninda Badibabi, Jean Louis Lumaliza Solomo, Medard Ilunga, Sonja C. Bernhard, Francis Regongbenga Dama, Josué Amici Heradi, Guylain Mandula, Papy Kavunga Lukula, Clélia Bardonneau, Hélène Mahenzi Mbembo, Digas Ngolo Tete, Sophie Delhomme, Antoine Tarral
Publikováno v:
The Lancet. 391:144-154
Summary Background Few therapeutic options are available to treat the late-stage of human African trypanosomiasis, a neglected tropical disease, caused by Trypanosoma brucei gambiense (g-HAT). The firstline treatment is a combination therapy of oral
Autor:
Andrea Kuemmerle, Olaf Valverde Mordt, Sylvain Mutanda, Nono Mubwa, Johannes Blum, Pathou Nganzobo, Séverine Blesson, Caecilia Schmid, Digas Ngolo Tete, Victor Kande, Mays Kisala, Wilfried Mutombo, Ismael Lumpungu, Medard Ilunga, Salah Ghabri
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 6, Iss 11, p e1920 (2012)
BACKGROUND: Trypanosoma brucei (T.b.) gambiense Human African trypanosomiasis (HAT; sleeping sickness) is a fatal disease. Until 2009, available treatments for 2(nd) stage HAT were complicated to use, expensive (eflornithine monotherapy), or toxic, a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b6ceeeecd5478b4a521ba7c2de4ed6a